1.Klevens RM, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. Journal of the American Medical Association 2007; 298: 1763–1771.
2.Vandenesch F, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence. Emerging Infectious Diseases 2003; 9: 978–984.
3.Moran GJ, et al. Methicillin-resistant Staphylococcus aureus in community-acquired skin infections. Emerging Infectious Diseases 2005; 11: 928–930.
4.CDC. Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison – Mississippi, 2000. Morbidity and Mortality Weekly Report 2001; 50: 919–922.
5.CDC. Methicillin-resistant Staphylococcus aureus infections in correctional facilities – Georgia, California, and Texas, 2001–2003. Morbidity and Mortality Weekly Report 2003; 52: 992–996.
6.CDC. Outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections – Los Angeles County, California, 2002–2003. Morbidity and Mortality Weekly Report 2003; 52: 88.
7.Turabelidze G, et al. Personal hygiene and methicillin-resistant Staphylococcus aureus infection. Emerging Infectious Diseases 2006; 12: 422–427.
8.Lindenmayer JM, et al. Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community. Archives of Internal Medicine 1998; 158: 895–899.
9.CDC. Methicillin-resistant Staphylococcus aureus infections among competitive sports participants –Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000–2003. Morbidity and Mortality Weekly Report 2003; 52: 793–795.
10.Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerging Infectious Diseases 2005; 11: 526–532.
11.Kazakova SV, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. New England Journal of Medicine 2005; 352: 468–475.
12.Zinderman CE, et al. Community-acquired methicillin-resistant Staphylococcus aureus among military recruits. Emerging Infectious Diseases 2004; 10: 941–944.
13.Lee NE, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus skin infections among HIV-positive men who have sex with men. Clinical Infectious Diseases 2005; 40: 1529–1534.
14.Skiest D, et al. Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Medicine 2006; 7: 361–368.
15.Mathews WC, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. Journal of Acquired Immune Deficiency Syndrome 2005; 40: 155–160.
16.Crum-Cianflone NF, Burgi AA, Hale BR. Increasing rates of community-acquired methicillin-resistant Staphylococcus aureus infections among HIV-infected persons. International Journal of STD AIDS 2007; 18: 521–526.
17.Thompson K, Torriani F. Community-associated methicillin-resistant Staphylococcus aureus in the patient with HIV infection. Current HIV/AIDS Reports 2006; 3: 107–112.
18.Bozzette SA, et al. Expenditures for the care of HIV-infected patients in the era of highly active antiretroviral therapy. New England Journal of Medicine 2001; 344: 817–823.
19.Nguyen MH, et al. Nasal carriage of and infection with Staphylococcus aureus in HIV-infected patients. Annals of Internal Medicine 1999; 130: 221–225.
20.von Eiff C, et al. Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. New England Journal of Medicine 2001; 344: 11–16.
21.Szumowski JD, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clinical Infectious Diseases 2009; 49: 118–121.
22.Wertheim HF, et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infectious Diseases 2005; 5: 751–762.
23.Cenizal MJ, et al. Prevalence of and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization in HIV-infected ambulatory patients. Journal of Acquired Immune Deficiency Syndrome 2008; 48: 567–571.
24.Hidron AI, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clinical Infectious Diseases 2005; 41: 159–166.
25.Gorwitz RJ, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001–2004. Journal of Infectious Diseases 2008; 197: 1226–1234.
26.Kuehnert MJ, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001–2002. Journal of Infectious Diseases 2006; 193: 172–179.
27.Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing; Nineteenth Informational Supplement. M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
28.McDougal LK, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. Journal of Clinical Microbiology 2003; 41: 5113–5120.
29.Limbago B, et al. Characterization of methicillin-resistant Staphylococcus aureus isolates collected in 2005 and 2006 from patients with invasive disease: a population-based analysis. Journal of Clinical Microbiology 2009; 47: 1344–1351.
30.Altman DG. Practical Statistics for Medical Research. Boca Raton: Chapman & Hall/CRC, 1991.
31.Shet A, et al. Colonization and subsequent skin and soft tissue infection due to methicillin-resistant Staphylococcus aureus in a cohort of otherwise healthy adults infected with HIV type 1. Journal of Infectious Diseases 2009; 200: 88–93.
32.Madariaga MG, Ullrich F, Swindells S. Low prevalence of community-acquired methicillin-resistant Staphylococcus aureus colonization and apparent lack of correlation with sexual behavior among HIV-infected patients in Nebraska. Clinical Infectious Diseases 2009; 48: 1485–1487.
33.Padoveze MC, et al. Staphylococcus aureus nasal colonization in HIV outpatients: persistent or transient? American Journal of Infection Control 2008; 36: 187–191.
34.Seybold U, et al. Prevalence and risk factors of nasal colonization with Staphylococcus aureus – association with HIV infection in older patients. Scandinavian Journal of Infectious Diseases 2009; 41: 63–66.
35.Giuliani M, et al. No evidence of colonization with community-acquired methicillin-resistant Staphylococcus aureus in HIV-1-infected men who have sex with men. Epidemiology and Infection 2010; 138: 738–742.
36.Moran GJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. New England Journal of Medicine 2006; 355: 666–674.
37.Li M, et al. Evolution of virulence in epidemic community-associated methicillin-resistant Staphylococcus aureus. Proceedings of the National Academy of Sciences USA 2009; 106: 5883–5888.
38.Ramsetty SK, et al. Risks for methicillin-resistant Staphylococcus aureus colonization or infection among patients with HIV infection. HIV Medicine 2010; 1389–394.
39.Pugliese A, et al. Phagocytic activity in human immunodeficiency virus type 1 infection. Clinical Diagnostic Laboratory Immunology 2005; 12: 889–895.
40.Diep BA, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Annals of Internal Medicine 2008; 148: 249–257.
41.Hota B, et al. Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections at a public hospital: do public housing and incarceration amplify transmission? Archives of Internal Medicine 2007; 167: 1026–1033.